Free Access
Med Sci (Paris)
Volume 21, Décembre 2005
Métabolisme glucidolipidique et risque cardiovasculaire: Nouvelle approches
Page(s) 69 - 72
Section M/S revues
Published online 15 November 2005
  1. Desnick RJ. Enzyme replacement therapy for Fabry disease : lessons from two alpha-galactosidase A orphan products and one FDA approval. Expert Opin Biol Ther 2004; 4 : 1167–76. [Google Scholar]
  2. Bouvenot G, Vray M. Essais cliniques. Théorie, pratique et critique. Collection Statistiques en biologie. Paris: Flammarion Médecine-Sciences, 1990. [Google Scholar]
  3. Bergmann JF. Les dix commandements. Pratiques Médicales et Thérapeutiques 2001; 14 : 29–30. [Google Scholar]
  4. Spriet A, Simon B. Méthodologie des essais cliniques des médicaments, 3rd ed. Basel : Karger, 1993. [Google Scholar]
  5. Florey CD. Sample size for beginners. Br Med J 1993; 306 : 1181–4. [Google Scholar]
  6. Hansen WB, Collins MN. Seven ways to increase power without increasing. NIDA Res Monogr 1994; 142 : 184–95. [Google Scholar]
  7. Al-Marzouki S, Evans S, Marshall T, Roberts I. Are these data real ? Statistical methods for the detection of data fabrication clinical trials. Br Med J 2005; 331 : 267–70 [Google Scholar]
  8. Haffner ME, Whitley J, Moses M. Two decades of orphan product development. Nat Rev Drug Discov 2002; 1 : 821–5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.